- What is AptaTeck Bio's primary focus?
- AptaTeck Bio specializes in immuno-diagnostic assays, developing proprietary technology based on an amplification probe for highly sensitive immuno-assays using both antibodies and aptamers.
- When was AptaTeck Bio founded?
- AptaTeck Bio was founded in January 2009.
- What is the current operational status of AptaTeck Bio?
- AptaTeck Bio is currently inactive, having ceased operations in January 2015.
- Where is AptaTeck Bio headquartered?
- AptaTeck Bio is headquartered in Jerusalem, Jerusalem District, Israel.
- What is AptaTeck Bio's employee count?
- AptaTeck Bio has an employee count in the 1-10 range.
- Who is a co-founder of AptaTeck Bio?
- Ofer Nussbaum, PhD. is a co-founder and CTO of AptaTeck Bio.
- What kind of technology does AptaTeck Bio utilize?
- AptaTeck Bio's technology is based on signal amplification designed to generate specific, highly sensitive, accurate, and reproducible immune diagnostics assays, compatible with various platforms like ELISA and flow cytometry.
- What types of molecules can AptaTeck Bio's technology detect?
- AptaTeck Bio's technology is suitable for detecting various target molecules, including biomarkers, viral and bacterial antigens, nucleic acids, cell surface, and soluble antigens.
